Addressing the crisis of care for sickle-cell disease.
Morris
K
K
D000986:Antisickling Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D003422:Critical Care; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D009569:Nitric Oxide / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy* / Q000517:prevention & control; D012805:Sickle Cell Trait / Q000188:drug therapy*; D006113:United Kingdom; D014481:United States
D000986:Antisickling Agents; D009569:Nitric Oxide; D006918:Hydroxyurea